Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
January 14 2021 - 5:12PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of January 2021
Commission
File Number 001-37381
MEDIGUS LTD.
(Translation of registrant’s name into English)
Omer
Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
EXPLANATORY
NOTE
Medigus
Ltd., or the Company, hereby furnishes the following documents:
|
(i)
|
Notice
and Proxy Statement with respect to the Company’s extraordinary general meeting of the shareholders to be held on February
11, 2021, describing the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting
and various other details related to the meeting.
|
|
(ii)
|
a
Proxy Card whereby holders of American depository shares, evidenced by American depositary receipts, of the Company may vote
at the meeting without attending in person.
|
|
(iii)
|
a
Proxy Card whereby holders of American depository shares, evidenced by American depositary receipts, of the Company may vote at
the meeting without attending in person.
|
This
Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-238162 and No.
333-237774) and Form S-8 (File No. 333-206803, No. 333-221019 and No. 333-229429).
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
MEDIGUS LTD.
|
|
|
|
Date: January 14, 2021
|
By:
|
/s/ Tatiana Yosef
|
|
|
Tatiana Yosef
|
|
|
Chief Financial Officer
|
2
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Sep 2023 to Sep 2024